Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Outcome of patients with ovarian metastatic tumors. Report of 83 cases and review
12rd Department of Obstetrics and Gynecology, Greece
2Histopathology Department, Aretaieio Hospital, University of Athens, Athens, Greece
*Corresponding Author(s): E. Salamalekis E-mail:
The aim of the study was to review patients with metastatic ovarian tumors in relation to their outcome and clinical characteristics.
Methods: It was a retrospective study including 83 patients with histopathological diagnosis of metastatic ovarian tumor. The examined parameters include age of the patients, origin of the tumor, consistency and appearance of the tumor, histological type and 5-year survival.
Results: The 5-year survival time of patients with metastatic ovarian tumors originating from the genital tract was 14.8% and for metastatic ovarian tumors originating outside the genital tract 5.4%.
Conclusion: The presence of metastatic ovarian tumors should always be included in the differential diagnosis of a pelvic mass. Difficulties in identification of the primary tumor site are present mainly in cases of metastatic tumors from the colon, while metastasis to the ovary from the breast tends to form small nodules in the ovary.
Metastatic ovarian tumor; Ovarian cancer; Ovarian cyst; Ovarian malignancy; Krukenberg tumor
E. Salamalekis,P. Bakas,K. Sykiotis,I. Saloum,K. Kontogianni,E. Pabameto,A. Pafiti,G. Creatsas. Outcome of patients with ovarian metastatic tumors. Report of 83 cases and review. European Journal of Gynaecological Oncology. 2004. 25(6);713-715.
[1] Holtz F., Hart W.R. Cancer, 1982, 50, 2438.
[2] Janovski N.A., Paramandlem TL.: "Ovarian tnmors". In: "Major Problems in Obstetrics and Gynecology". Saunders Co., 1973.
[3] Young R.H., Path F.R.C., Scully R.E.: "Metastatic tumors of the ovary". In: "Blausteins Pathology of the Female Genital Tract". 4th edition, Springer-Verlag, 1994, 939.
[4] Ulbright TM., Roth L.M., Stehman F.B. Cancer, 1984, 53, 1164.
[5] Yakushiji M., Tazaki T., Nishimura H., Kato T.: "Krukenberg tumors of the ovary: a clinicopathological analysis of 112 cases" Acta Obstet. Gynecol. Jpn., 1987, 39, 479.
[6] Lumb G., Mackenzie Dh.: "The incidence of metastases in adrenal glands and ovaries removed for carcinoma of the breast". Cancer, 1959, 12, 521.
[7] Fox H., Langley F.A. In: "Tumors of the Ovary". London, Hememann, 1976, 300.
[8] Hashimoto N.Y., Yamamoto T., Kamiura S., Seino H., Ohira H., Sawai K. et al.: "Metastatic ovarian tumors: A review of 64 cases". Gynecol. Oncol., 2003, 89, 314.
[9] Webb M.J., Decker D.G., Mussey E.: "Cancer metastatic to the ovary, factors influencing survival". Obstet. Gynecol., 1975, 45, 391.
[10] Horie K., Konishi I., Fujii S., Kozasa H., Noda Y., Okamura H., Mori T.: "A clinical study of metastatic ovarian tumors". Obstet. Gynecol., 1986, 38, 435.
[11] Woodruff J.D., Novak E.R.:'The Krukenberg tumor study of 48 cases from the ovarian tumor registry". Obstet. Gynecol., 1960, 15, 351.
[12] Johanson H.: "Clinical aspects of metastatic ovarian cancer of extragenital origin". Acta Obstet. Gynecol. Scand., 1960, 39, 681.
[13] Hale R.W.: "Krukenberg tumors of the ovaries: a review of 81 records". Obstet. Gynecol., 1968, 32, 221.
[14] Chang T.C., Changchien C.C., Tseng C.W., Lai C.H.. Tseng C.J et al.: "Retrograde lymphatic spread: A likely route for metastatic ovarian cancers of gastrointestinal origin". Gynecol. Oneal., 1997, 66, 372.
Top